Incretin Physiology and Beta-cell Function Before and After Weight-loss
NCT ID: NCT00625040
Last Updated: 2014-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
10 participants
OBSERVATIONAL
2008-01-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Gastric Bypass Surgery on Pancreatic Islets and Incretin Function
NCT01559779
Physiological Effects of Gastric Sleeve Operation
NCT03046186
Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin
NCT04055025
Incretin Hormone Antagonism After Bariatric Surgery
NCT03950245
Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss
NCT01094054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Obese patients without diabetes with a Body Mass Index \> 37 kg/m2
Oral glucose tolerance test (OGTT), isoglycemic iv. clamp, liquid meal test, gastric emptying rate
OGTT: The test is performed with 50 g of glucose deluded in 300 ml water
Isoglycemic iv. clamp: Iv. glucose infusion mimicking the glucose response curves from the OGTT
Liquid Meal test: The test is performed with 100g of formula milk deluded in 300 ml. water
Gastric Emptying Rate: Paracetamol absorption test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral glucose tolerance test (OGTT), isoglycemic iv. clamp, liquid meal test, gastric emptying rate
OGTT: The test is performed with 50 g of glucose deluded in 300 ml water
Isoglycemic iv. clamp: Iv. glucose infusion mimicking the glucose response curves from the OGTT
Liquid Meal test: The test is performed with 100g of formula milk deluded in 300 ml. water
Gastric Emptying Rate: Paracetamol absorption test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal OGTT (75 g of glucose) according to WHO's criteria
* Patients fulfilling the criteria for laparoscopic gastric banding
* Normal Hemoglobin
* Informed consent
Exclusion Criteria
* Nephropathy (s-creatinin \> 130 µM or albuminuria)
* Relatives (parents/siblings) with T2DM
* Medical treatment witch cannot be stopped for 12 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
European Foundation for the Study of Diabetes
OTHER
Novo Nordisk A/S
INDUSTRY
Glostrup University Hospital, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katrine Bagge Hansen
MD, Ph.d
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katrine Bagge Hansen, MD
Role: PRINCIPAL_INVESTIGATOR
Glostrup University Hospital, Copenhagen
Filip K Knop, MD, PhD
Role: STUDY_DIRECTOR
Gentofte Hospital
Steen Larsen, MD, DMSc
Role: STUDY_DIRECTOR
Glostrup University Hospital, Copenhagen
Jens Juul Holst, MD,DMSc
Role: STUDY_DIRECTOR
University of Copenhagen
Viggo Kristensen, MD
Role: STUDY_CHAIR
Glostrup University Hospital, Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glostrup Hospital
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GB-INK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.